Adamis Pharmaceuticals | ADMP - Capital Y Las Reservas



Capital Y Las Reservas Cambio Fecha
Adma Biologics USD 477.32M 46.13M 2025-12
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Brainstorm Cell Therapeutics USD -7.69M 1.64M 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Merck USD 51.85B 2.79B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
RedHill Biopharma USD -4.41M 271K 2025-06